Skip to main content

Table 2 Characteristics of the prescriptions in the first year after index date

From: Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database

Treatment (no. of users) No. of scripts No. of scripts per patient Average quantity per script (SD) Average duration per script in days (SD) Median duration per script in days
Asacol® and generics (699) 5994 8.6 146 (102) 24.0 (12.8) 30
Pentasa® (208) 1627 7.8 111.7 (92.9) 19.8 (12.7) 30
Salofalk® (817) 7317 9.0 140.0 (96.8) 23.0 (14.1) 30
Mezavant® (147) 2124 14.4 77.1 (40.5) 27.2 (11.7) 30
  1. SD, standard deviation.